diabetes 1 - Jacobi Medical Center

Download Report

Transcript diabetes 1 - Jacobi Medical Center

Jacobi
Ambulatory Care Service
Type II Diabetes
Matthew Love, M.D.
Case 1
Fred Banting, a 52 year-old man, complains of polyuria
and polydypsia for three weeks. On questioning, he
also admits to dizziness on standing.
On exam, his BP is 135/80, Pulse 95. He is 5’8” tall,
weighs 220# and has acanthosis nigricans.
Urine dipstick is ++ for glucose. Fingerstick glucose is
188. Point of Care Hemoglobin A1c is 8.3%.
Does this patient have Diabetes?
Jacobi
Ambulatory Care Service
Diagnosis
Method
Threshold Value Advantages
Fasting Plasma
Glucose
> 126 mg/dl
•Time since last
meal easy to
define
•ADA preferred
•Cheap
•Inconvenient
•Unstable
Random glucose
>200 + symptoms
•Convenient
•Less
reproducible
HbA1c
≥ 6.5%
•Correlates with
disease process
•Stable
•Cost
OGGT
>200 @ 2 hours
•Pregnancy
•Cumbersome
Jacobi
Ambulatory Care Service
Disadvantages
Prediabetes
• Impaired fasting glucose: 100 < FPG < 126
• Impaired glucose tolerance: OGTT result at 2h
between 140-199.
• Hemoglobin A1c of 6.0% – 6.4%
Jacobi
Ambulatory Care Service
Remember the Pathogenesis
Jacobi
Ambulatory Care Service
Remember the Pathophysiology
Jacobi
Ambulatory Care Service
Case 2
Dulce Diente is a 37 year-old female with a family history of diabetes.
She wants to be checked for diabetes because she has gained a lot of
weight, she keeps getting yeast infections and her urine tastes sweet.
Physical exam is normal except for a BMI of 29.
FPG checked by fingerstick on her father’s glucometer has been 110-120.
Point of Care HbA1c comes back at 6.8%
Should she be started on medicine? Is there anything that can
be done to prevent the progression of her diabetes?
Jacobi
Ambulatory Care Service
Diabetes Prevention Program
Results
Jacobi
Ambulatory Care Service
Diabetes Prevention Program
Change in weight & Physical Activity
Jacobi
Ambulatory Care Service
PREVENTION TRIALS
Jacobi
Ambulatory Care Service
Case 3
Isabel Fadiman is a 41 year-old African-American female who presents
for a check-up. She has no complaints. Past medical history includes
gestational diabetes during her last pregnancy five years ago. Family
history is positive for two brothers and both parents with Type 2 DM.
She does not smoke.
On exam, her BP is 120/80 and her BMI is 27. There is no acanthosis
nigracans or any other abnormality.
Should she be screened for diabetes?
Jacobi
Ambulatory Care Service
Diabetes Screening Recommendations
Organization
Recommendation
US Preventive Services
Task Force
• The USPSTF concludes that the current evidence is
insufficient to assess the balance of benefits and harms of
screening for type 2 diabetes in asymptomatic adults with
blood pressure of 135/80 mm Hg or lower.
• The USPSTF recommends screening for type 2 diabetes in
asymptomatic adults with sustained blood pressure (either
treated or untreated) greater than 135/80 mm Hg.
American Diabetes
Association
• For adults who do not have diabetes risk factors, consider
screening every 3 y starting at age 45 y, particularly if body
mass index >25 kg/m2
• Screen adults < 45 y of age if they are overweight and have
another diabetes risk
Factor
Canadian Diabetes
Association
• Evaluate all patients for type 2 diabetes risk annually
• Screen patients without diabetes risk factors every 3 y
starting at age 40 y
• Consider earlier, more frequent screening for patients with
diabetes risk factors
Jacobi
Ambulatory Care Service
Risk Factors for Type 2 Diabetes
• Age > 45 y
• First-degree relative with type 2 Diabetes
• African-American, Hispanic, Asian, Pacific Islander, or Native
American ethnicity
• History of gestational diabetes or delivery of infant weighing ≥9 lbs
• Polycystic ovary syndrome
• Overweight, especially abdominal obesity
• Cardiovascular disease,hypertension, dyslipidemia, or other
metabolic syndrome features
Jacobi
Ambulatory Care Service
Initial Evaluation
• Symptoms
• Exam – BP, BMI, Feet
• Labs
–
–
–
–
HbA1c
Ualb/cr
Chemistry (Cr, LFTs)
EKG
• Referrals
–
–
–
–
Dietician
Glucometer Teaching
Ophthalmology
Podiatry
Jacobi
Ambulatory Care Service
Blood Glucose Monitoring
Jacobi
Ambulatory Care Service
Glucometer Operation
Jacobi
Ambulatory Care Service
Case 4
Matt Forman is a 54 year-old man with newly diagnosed Type II
Diabetes. His FPG is 148 and his HbA1c is 7.8% . Physical is normal
except for BMI of 28. Except for the glucose values, his laboratory
exams are normal.
How should he be treated?
Jacobi
Ambulatory Care Service
Treatment non-pharmacologic Diet
• Carbohydrates




Should comprise 45%-65% of total calories
No concentrated sweets (soda, juice, desserts)
No white starches (especially rice and pasta)
Fresh vegetables and fruits rather than canned
• Fats
 Should comprise < 30% of total calories
 Saturated fats should be < 7%
Jacobi
Ambulatory Care Service
Treatment non-pharmacologic Exercise
Jacobi
Ambulatory Care Service
Treatment pharmacologic Oral Agents
Jacobi
Ambulatory Care Service
Metformin
• No weight gain
• No hypoglycemia
• Cheap, generic, old
• GI side effects frequent
• Rare but serious lactic
acidosis
• Start at 500 bid with meals
• Titrate up quickly to 1000 bid
or 850 tid
Jacobi
Ambulatory Care Service
Sulfonylurea
• Cheap, generic, old
• Equally effective
• May cause
hypoglycemia
• Weight gain
• Start at low dose,
increase gradually
Jacobi
Ambulatory Care Service
Thiazolidinediones TZD
• Increase glucose uptake
and decrease glucose
production
• Equally effective
• May preserve beta-cell
function
• Newer, more expensive
• Fluid retention
• May cause xs MIs
Jacobi
Ambulatory Care Service
Incretin mimetics
Jacobi
Ambulatory Care Service
Incretin-based therapies
Jacobi
Ambulatory Care Service
Alpha-glucosidase Inhibitors
• Lower postprandial
glucose and A1c
• Less potent
• No weight gain
• Cause flatulence
• Contraindicated in
cirrhosis
• Take with first bite of
meal
Jacobi
Ambulatory Care Service
Case 4
Matt Forman is a 54 year-old man with newly diagnosed Type II
Diabetes. His FPG is 148 and his HbA1c is 7.8% . Physical is normal
except for BMI of 28. Except for the glucose values, his laboratory
exams are normal.
After 6 months of a diabetic diet and increased exercise, his HbA1c is 8.1%
How should he be treated?
Jacobi
Ambulatory Care Service
Case 4
Matt Forman is a 54 year-old man with newly diagnosed Type II
Diabetes. His FPG is 148 and his HbA1c is 7.8% . Physical is normal
except for BMI of 28. Except for the glucose values, his laboratory
exams are normal.
After 6 months of a diabetic diet and increased exercise, his HbA1c is 8.1%
After 6 months of Metformin at a dose of 1000 mg bid, his HbA1c is 7.1%
How should he be treated?
What is the glycemic control target?
Jacobi
Ambulatory Care Service
Jacobi
Ambulatory Care Service
Glycemic Control Target:
Good Control Reduces Microvascular Complications
Jacobi
Ambulatory Care Service
Glycemic Control Target:
The UKDPS – the largest and longest study in Type II DM
• Microvascular complications were reduced 25% in the intensivetherapy group
• Epidemiologic analysis showed that for every 1% reduction of
HbA1c:
↓
↓
↓
↓
35% reduction in microvascular complications
25% reduction in diabetes related deaths
7% reduction in all cause mortality
18% reduction in myocardial infarction
• No lower threshold
Jacobi
Ambulatory Care Service
Glycemic Control Target:
Macrovascular Complications
ACCORD trial – Action to Control Cardiovascular Risk in Diabetes
Jacobi
Ambulatory Care Service
Glycemic Control Target:
Current Recommendations from the ADA:
• The Benefits of Intensive Glycemic Control on Macrovascular
Complications vary based on the population being treated
– Those most likely to benefit from intensive control are those with
shorter duration of DM, no known vascular disease, and without
severe hypoglycemia
– The risk of intensive glycemic control may outweigh the benefits in
those with a long duration of DM, known vascular disease, or
symptomatic severe hypoglycemia
Jacobi
Ambulatory Care Service
Case 4
Matt Forman is a 54 year-old man with newly diagnosed Type II
Diabetes. His FPG is 148 and his HbA1c is 7.8% . Physical is normal
except for BMI of 28. Except for the glucose values, his laboratory
exams are normal.
After 6 months of a diabetic diet and increased exercise, his HbA1c is 8.1%
After 6 months of Metformin at a dose of 1000 mg bid, his HbA1c is 7.1%
How should he be treated?
A second agent should be added
Jacobi
Ambulatory Care Service
Case 4 – Algorithm
Jacobi
Ambulatory Care Service
Case 5
Norman P. Hagedorn is a 64 year-old man with Type II Diabetes for
12 years. He also has CAD, s/p MI and CABG, HTN, gout, and BPH.
Medications include metformin, glyburide, pioglitazone, and sitagliptin
at maximal doses. Previously, his HbA1c were always in the 7.0-7.9%
range, however his last two HbA1cs, three months apart, are 9.8% and
10.9%. Previous attempts to introduce insulin injections have met with
adamant refusals.
What might have happened to his glycemic control?
Jacobi
Ambulatory Care Service
Jacobi
Ambulatory Care Service
Jacobi
Ambulatory Care Service
Jacobi
Ambulatory Care Service
Case 5
Norman P. Hagedorn is a 64 year-old man with Type II Diabetes for
12 years. He also has CAD, s/p MI and CABG, HTN, gout, and BPH.
Medications include metformin, glyburide, pioglitazone, and sitagliptin
at maximal doses. Previously, his HbA1c were always in the 7.0-7.9%
range, however his last two HbA1cs, three months apart, are 9.8% and
10.9%.
Bedtime NPH 10 Units is added to his metformin. Glyburide , pioglitazone,
and sitagliptin are discontinued. After following the titration schedule
for six weeks, he is on 25 units NPH and morning fingersticks are 95125.
Jacobi
Ambulatory Care Service
Case 5
Norman P. Hagedorn is a 64 year-old man with Type II Diabetes for 12 years. He
also has CAD, s/p MI and CABG, HTN, gout, and BPH. Medications include metformin,
glyburide, pioglitazone, and sitagliptin at maximal doses. Previously, his HbA1c were
always in the 7.0-7.9% range, however his last two HbA1cs, three months apart, are 9.8%
and 10.9%.
Bedtime NPH 10 Units is added to his metformin. Glyburide , pioglitazone, and sitagliptin are
discontinued. After following the titration schedule for six weeks, he is on 25 units NPH
and morning fingersticks are 95-125.
After 3 months with continued good am fingersticks, HbA1c is 8.5%. What
would you do now?
Pre-dinner fsg are 160-180, so NPH is switched to glargine and eventually
titrated up to a dose of 35 U daily.
Now am fsg are 80-110 and pre-dinner are 95-120.
3 months later HbA1c is 8.0%. What would you do now?
Jacobi
Ambulatory Care Service
Jacobi
Ambulatory Care Service
Diabetes Treatment Algorithm
Jacobi
Ambulatory Care Service
Diabetes and Hypertension - UKDPS
For each 10 mm decrease
in SBP:
• Microvascular
complications ↓ 13%
• Death ↓ 15%
• MI ↓ 11%
Jacobi
Ambulatory Care Service
Diabetes & Lipids - Heart Protection Study
 Primary prevention with risk factors
(hypertension, diabetes, and CVA)
 2x2 factorial design
simvastatin 40 mg/day, antioxidant cocktail
(600 mg vitamin E, 250 mg vitamin C, 20 mg beta
carotene)
 N = 20,000; subgroups include:
Women (n ~ 5,000)
Elderly (>65, n ~ 10,000)
Diabetics (n ~ 6,000)
Stroke (n ~ 3,000)
Hypertension (n ~ 8,000)
Noncoronary vascular disease (n ~ 7,000)
Low to average blood cholesterol (n ~ 8,000)
Jacobi
Ambulatory Care Service
Heart Protection Study: Vascular
Events by Baseline Disease
Risk ratio and 95% CI
Baseline feature
Previous MI
Simvastatin
(n=10,269)
Placebo
(n=10,267)
1007
1255
914
1234
CVD
182
215
PVD
332
427
Diabetes
279
369
All patients
2042
(19.9%)
2606
(25.4%)
Other CHD (not MI)
Statin
better
Statin
worse
No prior CHD
 24 ± 2.6%
(2P <0.00001)
0.4 0.6 0.8 1.0 1.2 1.4
Jacobi
Ambulatory Care Service
Diabetes/HTN & Lipids – Steno-2
Intervention was intensive
lowering of BP, lipids,
and A1c
Macrovascular
complications reduced
50% in intensive
treatment group over 13
years
Jacobi
Ambulatory Care Service
Diabetes & HTN & Lipids
Clinical Parameter
Target
LDL cholesterol
< 100
Blood Pressure
< 130/80
HbA1c
< 7%
Jacobi
Ambulatory Care Service
The Routine Followup Visit
•
Glycemic Control
– Fingersticks
• Daily if previously at target and on orals or glargine
• More frequently if not at target or more complicated regimen
– Symptoms of hypoglycemia & hyperglycemia
• Adherence to Diet, Exercise, & Medication
• Ongoing Education
• Ongoing Screening for longterm microsvascular
complications (at least yearly)
– Nephropathy (Ualb/cr), Neuropathy (monofilament) , retinopathy
• Control of other macrovascular risk factors
Jacobi
Ambulatory Care Service
• LDL < 100
• BP < 130/80
Question 1 – What are the symptoms
of diabetes?
• Hyperglycemia
- Tm of kidney for reabsorption of glucose > 160, sugar pulls
water, leading to polyuria; the dehydration stimulates thirst
- Polyphagia and weight loss
- Blurry vision – glucose deposits in cornea
- Yeast infections
• Volume Depletion
- Orthostatic dizziness
• Nonspecific symptoms
– Headaches, weakness
Jacobi
Ambulatory Care Service
Question 2 – the following patient is taking 25 U of NPH in the morning and
16 Units at bedtime. What adjustments would you make to her regimen?
Day
8 a.m. fasting
6pm pre-dinner
S
140
120
M
174
100
T
144
220
W
155
184
Th
151
84
F
133
65
Sa
130
112
S
149
108
M
145
Jacobi
Ambulatory Care Service
10 pm bedtime
179
188
Question 3 – this patient is using 45 Units of Lantus at bedtime and has the
following fingersticks:
Day
8 a.m. fasting
6pm pre-dinner
S
90
85
M
82
85
T
99
106
W
10 pm bedtime
83
Th
82
84
F
96
112
Sa
100
88
S
120
123
M
100
88
HBA1c is 7.8 % What could explain this? What would you recommend?
Jacobi
Ambulatory Care Service
Question 4 – this patient is taking 1000 mg of Metformin bid and has the
following fingersticks:
Day
8 a.m. fasting
6pm pre-dinner
10 pm bedtime
S
90
88
125
M
82
99
123
T
99
101
165
W
82
87
101
Th
82
94
112
F
96
96
140
Sa
100
121
130
S
120
88
115
M
100
99
113
What would you expect the HbA1c to be?
Jacobi
Ambulatory Care Service
Translating the A1c into Estimated Average Glucose Values
Jacobi
Ambulatory Care Service